304840 — Peoplebio Income Statement
0.000.00%
- KR₩33bn
- KR₩41bn
- KR₩4bn
Annual income statement for Peoplebio, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 508 | 577 | 4,445 | 4,453 | 3,732 |
| Cost of Revenue | |||||
| Gross Profit | -140 | -771 | 1,356 | 1,405 | 1,351 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 5,071 | 7,811 | 16,138 | 20,725 | 15,315 |
| Operating Profit | -4,563 | -7,234 | -11,693 | -16,273 | -11,583 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -4,383 | -4,942 | -15,003 | -17,382 | -12,173 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -4,383 | -4,942 | -15,003 | -17,382 | -12,173 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | -4,383 | -4,703 | -14,305 | -16,030 | -10,908 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -4,383 | -4,703 | -14,305 | -16,030 | -10,908 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -310 | -293 | -841 | -905 | -500 |
| Dividends per Share |